---
figid: PMC2783918__fig-10
figlink: /pmc/articles/PMC2783918/figure/f10/
number: FIG. 10
caption: Redox control of the cell cycle and cardiovascular diseases. Receptor-mediated
  ROS signaling can activate cellular proliferation during atherosclerosis. ROS generated
  from PDGF–ligand interaction can convert PTEN from the reduced form (phosphatase
  active) to the disulfide form (phosphatase inactive). Inactive PTEN can favor AKT
  phosphorylation, which in turn can phosphorylate GSK-3β, thereby stabilizing cyclin
  D1 and facilitating proliferation. ROS signaling can also initiate the ERK pathway,
  activating growth-promoting transcription factors, c-fos and c-myc. c-fos and c-myc
  can transcriptionally activate cyclin D1 and cyclin A expression, supporting proliferation.
  Nitric oxide inhibits proliferation by suppressing cyclin A expression and increasing
  p21 protein levels.
pmcid: PMC2783918
papertitle: Redox Control of the Cell Cycle in Health and Disease.
reftext: Ehab H. Sarsour, et al. Antioxid Redox Signal. 2009 Dec;11(12):2985-3011.
pmc_ranked_result_index: '7188'
pathway_score: 0.9533964
filename: fig-10.jpg
figtitle: Redox control of the cell cycle and cardiovascular diseases
year: '2009'
organisms: Homo sapiens
ndex: a201946b-dee9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2783918__fig-10.html
  '@type': Dataset
  description: Redox control of the cell cycle and cardiovascular diseases. Receptor-mediated
    ROS signaling can activate cellular proliferation during atherosclerosis. ROS
    generated from PDGF–ligand interaction can convert PTEN from the reduced form
    (phosphatase active) to the disulfide form (phosphatase inactive). Inactive PTEN
    can favor AKT phosphorylation, which in turn can phosphorylate GSK-3β, thereby
    stabilizing cyclin D1 and facilitating proliferation. ROS signaling can also initiate
    the ERK pathway, activating growth-promoting transcription factors, c-fos and
    c-myc. c-fos and c-myc can transcriptionally activate cyclin D1 and cyclin A expression,
    supporting proliferation. Nitric oxide inhibits proliferation by suppressing cyclin
    A expression and increasing p21 protein levels.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - MAPK1
  - JUND
  - JUN
  - CCND1
  - PDGFA
  - PTEN
  - PDGFD
  - PIK3CB
  - PIK3R4
  - PDGFC
  - PIK3R3
  - JUNB
  - FOSL2
  - CCNA2
  - PDGFB
  - CCNA1
  - AKT3
  - PIK3CA
  - PIK3CG
  - PIK3CD
  - FOSB
  - PIK3R6
  - FOSL1
  - AKT2
  - FOS
  - PIK3R5
  - AKT1
  - Cancer
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: PDGF)
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PDGF)
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PDGF)
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: CyclinA
  symbol: Cyclin_A
  source: bioentities_symbol
  hgnc_symbol: CCNA2
  entrez: '890'
- word: PDGF)
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: CyclinA
  symbol: Cyclin_A
  source: bioentities_symbol
  hgnc_symbol: CCNA1
  entrez: '8900'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
